% | $
Quotes you view appear here for quick access.

InVivo Therapeutics Holdings Corp. Message Board

  • factman777 factman777 Feb 17, 2013 9:53 PM Flag

    Update from BI Research

    As I posted earlier, Tom Bishop from BI Research has picked InVivo as his top pick for 2013. Check it out at:

    Last Thursday, he updated his subscribers after receiving a call back from the company. Here are some of the highlights:

    - recent sell off on heavy volume is due to fears concerning delays in hearing from the FDA on the HUD/HDE issue and possibly some Market Manipulation taking advantage of Investor fears.

    - InVivo is still muddling through FDA process and procedure, which he believe takes almost every company longer than they could anticipate.

    - as near as he can tell, prospects for approval of both the HUD/HDE issue and clearance to start the clinical trial are as bright as ever.

    - word is expected shortly on the HUD/HDE and there is no problem with the 4,000 incidence per year maximum issue.

    - company is learning they have to keep investors better informed going forward.

    - he also reaffirmed his BUY on InVivo.

5.602+0.082(+1.49%)10:06 AMEDT